SP
BMY icon

SWS Partners’s Bristol-Myers Squibb BMY Stock Holding History

SWS Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,578
Closed -$65.5K – 130
2024
Q2 		$65.5K Buy
+1,578
New +$70.6K 0.02% 148
2023
Q1 		– Sell
-37,002
Closed -$2.66M – 118
2022
Q4 		$2.66M Buy
37,002
+6,306
+21% +$475K 1.26% 26
2022
Q3 		$2.18M Sell
30,696
-7
-0% -$508 1.01% 39
2022
Q2 		$2.36M Sell
30,703
-8,018
-21% -$611K 1.99% 12
2022
Q1 		$2.83M Sell
38,721
-2,501
-6% -$168K 1.85% 14
2021
Q4 		$2.57M Buy
41,222
+3,350
+9% +$197K 1.46% 25
2021
Q3 		$2.24M Buy
37,872
+9,182
+32% +$605K 1.39% 26
2021
Q2 		$1.92M Buy
28,690
+775
+3% +$50.5K 1.25% 36
2021
Q1 		$1.76M Buy
27,915
+75
+0.3% +$4.67K 1.21% 36
2020
Q4 		$1.73M Buy
27,840
+1,799
+7% +$111K 0.77% 47
2020
Q3 		$1.57M Buy
26,041
+5,616
+27% +$338K 0.79% 36
2020
Q2 		$1.2M Sell
20,425
-3,053
-13% -$183K 1.53% 22
2020
Q1 		$1.31M Buy
+23,478
New +$1.44M 0.94% 35
2019
Q3 		$2.02M Buy
34,481
+634
+2% +$29.8K 1.19% 28
2019
Q2 		$1.49M Buy
+33,847
New +$1.58M 0.95% 40

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SWS Partners's BMY Position: Q3 2024 in Review

SWS Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 1,578 shares — an estimated $65.5K sold.

SWS Partners first reported a position in BMY in Q2 2019 and held it in 15 quarters. The position peaked at $2.83M in Q1 2022. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • SWS Partners reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • SWS Partners sold 1,578 Bristol-Myers Squibb shares in Q3 2024, an estimated $65.5K.
  • SWS Partners first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 15 quarters.
  • SWS Partners's Bristol-Myers Squibb position peaked at $2.83M in Q1 2022.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on SWS Partners's 13F filing for Q3 2024, filed 15 Oct 2024.